Underwood Patricia, Seiden Johanna, Carbone Kyle, Chamarthi Bindu, Turchin Alexander, Bader Angela M, Garg Rajesh
Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts Center for Nursing Excellence, Department of Nursing, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Endocr Pract. 2015 Mar;21(3):231-6. doi: 10.4158/EP14228.OR.
To describe a process improvement strategy that increased the identification of individuals with poorly controlled diabetes (glycated hemoglobin [A1C] ≥8%) undergoing elective surgery at a major academic medical center and increased their access to specialist care.
An algorithm was developed to ensure A1C measurements were obtained as per the American Association of Clinical Endocrinologists/American Diabetes Association (AACE/ADA) guidelines. The diabetes management team worked collaboratively with anesthesiologists, surgeons, and preoperative nurse practitioners to improve the glycemic control of patients with an A1C ≥8%.
Before implementing the program, A1C testing was recorded in 854 out of 2,335 (37%) patients with diabetes seen in the preoperative clinic from January 1, 2011 to December 31, 2012. The program was instituted in February 2013. From February 2013 to February 2014, A1C testing occurred in 1,236 out of 1,334 (93%) patients with diabetes. After excluding those scheduled for same day surgery, 228 patients were considered high risk with A1C ≥8%, and 175 were available for endocrine preoperative consultation. The program led to significant blood glucose level improvements on the day of surgery.
A process improvement strategy to evaluate and treat diabetes in the preoperative period of elective surgery patients was implemented by a multidisciplinary team (endocrinologists, nurse practitioners, anesthesiologists, and surgeons) and resulted in a substantial improvements in obtaining A1C tests, access to specialist diabetes care, and glycemic control on the day of surgery. The impact of improved glycemic control on hospital and surgical outcomes needs further evaluation.
描述一种流程改进策略,该策略提高了在一家大型学术医疗中心接受择期手术且糖尿病控制不佳(糖化血红蛋白[A1C]≥8%)的患者的识别率,并增加了他们获得专科护理的机会。
开发了一种算法,以确保按照美国临床内分泌学家协会/美国糖尿病协会(AACE/ADA)指南进行A1C测量。糖尿病管理团队与麻醉师、外科医生和术前执业护士合作,以改善A1C≥8%患者的血糖控制。
在实施该项目之前,2011年1月1日至2012年12月31日期间,在术前诊所就诊的2335名糖尿病患者中,有854名(37%)记录了A1C检测。该项目于2013年2月启动。从2013年2月到2014年2月,1334名糖尿病患者中有1236名(93%)进行了A1C检测。在排除当日手术患者后,228名患者被认为A1C≥8%为高风险,其中175名可接受内分泌术前咨询。该项目使手术当天的血糖水平有了显著改善。
一个多学科团队(内分泌学家、执业护士、麻醉师和外科医生)实施了一项在择期手术患者术前评估和治疗糖尿病的流程改进策略,在获取A1C检测、获得糖尿病专科护理以及手术当天的血糖控制方面取得了显著改善。血糖控制改善对医院和手术结局的影响需要进一步评估。